Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicaid Generic Dispensing Target Of 65% Proposed In Boyda/Emerson Bill

Executive Summary

State Medicaid programs would be financially penalized if they fail to reach target levels of generic dispensing for multiple-source drugs, under Reps. Nancy Boyda, D-Kan., and Jo Ann Emerson's, R-Mo., legislation to overturn the average manufacturer price system
Advertisement

Related Content

Drug Safety Concerns Help Depress U.S. Sales Forecasts From IMS Health
Drug Safety Concerns Help Depress U.S. Sales Forecasts From IMS Health
Medicaid AMPs Would Be Replaced By Pharmacy Acquistion Cost - House Bill
Medicaid AMPs Would Be Replaced By Pharmacy Acquistion Cost - House Bill
Medicaid AMPs Would Be Replaced By Pharmacy Acquistion Cost - House Bill
Medicaid AMPs Will Cut Average Pharmacy Revenue By Only 1 Percent – CMS
Advertisement
UsernamePublicRestriction

Register

PS048625

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel